ProShares UltraShort NASDAQ Biotechnology
10 hedge funds and large institutions have $1.34M invested in ProShares UltraShort NASDAQ Biotechnology in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
82% less capital invested
Capital invested by funds: $7.39M → $1.34M (-$6.05M)
Holders
10
Holding in Top 10
–
Calls
$1.51M
Puts
$548K
Top Buyers
| 1 | +$418K | |
| 2 | +$215K | |
| 3 | +$79K | |
| 4 |
Morgan Stanley
New York
|
+$5.2K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
+$3K |
Top Sellers
| 1 | -$2.72M | |
| 2 | -$1.78M | |
| 3 | -$549K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$518K |
| 5 |
CT
CMT Trading
Chicago,
Illinois
|
-$385K |